Science Day 2024
Science Day is an annual event hosted by the Saint Louis University School of Medicine Office of Research. This event features discussions with colleagues in science, topical presentations and a plenary speaker.
Daniela Salvemini, Ph.D. was the plenary speaker of Science Day 2024
The third annual School of Medicine Science Day was held on April 23, in the Education Union Auditorium. The plenary speaker was Daniela Salvemini, Ph.D..
Salvemini is the William Beaumont Professor and chair of the Department of Pharmacology and Physiology, professor in the Department of Psychiatry and Behavioral Neuroscience, and founding director of the Institute for Translational Science at Saint Louis University.
She received her B.Sc. in pharmacology from King’s College, London, and her Ph.D. in pharmacology from the University of London. She pursued postdoctoral studies at the William Harvey Research Institute in London and at Monsanto in the Department of Discovery Pharmacology in St. Louis. Before joining Saint Louis University, Salvemini spent 15 years in the private sector, where she led drug discovery and development efforts on novel analgesics and anti-inflammatory drugs.
Salvemini’s research interests include understanding the molecular mechanisms involved in neuropathic pain states and the discovery of non-opioid therapeutics. She serves on numerous committees, including National Institutes of Health study sections (the National Institute on Drug Abuse, the National Cancer Institute and the National Institute of Neurological Disorders and Stroke) and the NIH/NINDS external consultant board for the Preclinical Screening Platform for Pain, and boards, including the United States Association for the Study of Pain.
She is the founder of BioIntervene Inc., which is developing A3 adenosine receptor agonists for neuropathic pain and neuroinflammatory diseases, and founder of the St. Louis Translational Pain Research Forum. She has published more than 250 peer-reviewed articles and has been honored with several awards, including the Novartis Award in Pharmacology, the Outstanding Scientist Award from the Saint Louis Academy of Science, the Pharmacia-ASPET Award in Experimental Therapeutics and the Mitchell B. Max Award for Neuropathic Pain from the American Academy of Neurology.
Salvemini is a fellow of the Saint Louis Academy of Science, the National Academy of Inventors, the Saint Louis University Research Institute and the American Society of Pharmacology and Experimental Therapeutics. She has been continuously funded by the National Institutes of Health, the Department of Defense, foundations and the private sector.